Alerta De Seguridad para JenaValve prosthesis

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por JenaValve Technology.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2015-10-13
  • Fecha de publicación del evento
    2015-10-13
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: jenavalve prosthesis the medicines and healthcare products regulatory agency (mhra), united kingdom posted a medical device safety alert concerning jenavalve prosthesis, manufactured by jenavalve technology. the manufacturer has received notice that during a routine implantation in an ar patient using a size 27 jenavalve prosthesis, significant paravalvular leakage (pvl) occurred despite adequate positioning and deployment of the prosthesis. as pvl did not resolve following repeat balloon valvuloplasty, a valve-in-valve procedure had to be performed. prior to the procedure, a standardized mdct scan and software-mediated three dimensional reconstructions were used to calculate the patient’s native annular size and choose the corresponding prosthesis. annular dimensions in diastolic phase of the cardiac cycle were used. during the manufacturer’s investigation, repeat assessment of the mdct data in both diastolic and systolic phase was performed. it has become apparent that during systolic assessment, the patient’s annular size was significantly larger if compared to diastolic assessment and, in this specific case, potentially lead to prosthesis undersizing and pvl. the manufacturer has recommended the following measures for this issue:- always use systolic mdct data (10-20% of the cardiac cycle) to assess the largest annular dimension prior to selecting the corresponding prosthesis size to avoid potential undersizing and associated paravalvular leakage. perform systolic assessment of annular dimensions in both as and ar patients, as also in calcified as, systolic annular dimensions are larger in systole if compared to diastole, thus impacting prosthesis size selection. for details, please refer to the mhra website:https://www.Gov.Uk/government/publications/safety-information-from-manufacturers-field-safety-notices/field-safety-notices-5-to-9-october-2015 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 13 october 2015.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: JenaValve prosthesis
  • Manufacturer

Manufacturer